The ermA and ermC genes, which confer resistance to both erythromycin and clindamycin, were found in both patient groups, with ermA being more frequent in AD samples, as expected given its high level of carriage in CC9 isolates, a CC present only in cases. This evidence concerns the gene TMEM94 and Alzheimer disease.